Truxima 100 mg Patient Leaflet: Uses, Dosing & Safety
Quick summary Truxima contains rituximab, a monoclonal antibody used for several cancers and immune-related conditions. The exact dose, infusion time, and monitoring plan depend on the condition being treated and the prescribing leaflet used...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
Truxima contains rituximab, a monoclonal antibody used for several cancers and immune-related conditions. The exact dose, infusion time, and monitoring plan depend on the condition being treated and the prescribing leaflet used by the healthcare team.
Medical disclaimer: This page is a general summary of the patient information for Truxima 100 mg. It does not replace the official package leaflet, a pharmacist’s advice, or instructions from the prescribing clinician. Do not use this page to diagnose a condition or to change treatment.
Truxima is a monoclonal antibody containing rituximab. It is used in the treatment of several serious conditions, including some cancers and autoimmune diseases. Because it affects B-lymphocytes, treatment is usually given under specialist supervision.
What Truxima is used for
According to the leaflet content, Truxima may be used for:
- Non-Hodgkin’s lymphoma
- Chronic lymphocytic leukaemia
- Rheumatoid arthritis
- Granulomatosis with polyangiitis
- Pemphigus vulgaris
It may be used alone or together with other treatments, including chemotherapy in some cancer regimens.
What the Truxima package leaflet covers
The package leaflet is meant to help patients and caregivers understand how the medicine is used and what to watch for during treatment. It typically includes information on:
- the condition being treated
- how the infusion is given
- possible side effects
- precautions and monitoring
- what to discuss with the healthcare team before treatment
If you have the leaflet supplied with your medicine, it is the best source for product-specific instructions.
How Truxima is given
Truxima is given as an infusion into a vein. The infusion time can vary depending on the treatment plan and how well the person tolerates the medicine.
The first infusion may take longer, while later infusions may be given more quickly if the healthcare team decides it is appropriate. Monitoring during infusion is important because reactions can happen during administration.
Truxima dosing schedule
The dosing schedule depends on the condition being treated, the treatment protocol, and the patient’s response. The current content notes that schedules may differ between conditions such as lymphoma and rheumatoid arthritis.
Because the exact regimen is condition-specific, patients should confirm the planned schedule with the prescribing team or the official leaflet supplied with the product.
| Topic | What the leaflet summary says |
|---|---|
| Route | Given by infusion into a vein |
| Schedule | Varies by condition and treatment plan |
| Monitoring | Observation during infusion and follow-up as directed |
What a Truxima dosing calculator is used for
A dosing calculator may be used by healthcare professionals to help work out the planned dose based on treatment details such as weight and the condition being treated. It is a clinical tool, not a substitute for the official prescribing information.
Patients should not try to calculate or adjust their own dose. Any questions about the schedule should be directed to the prescribing team or pharmacist.
Common side effects mentioned in the leaflet summary
The current content highlights several possible side effects, including:
- Infusion reactions such as fever, chills, or rash
- Fatigue
- Infections
- Nausea
Some side effects can be serious. Any severe, persistent, or worrying symptoms should be reported to a healthcare professional promptly.
Is Truxima chemotherapy?
Truxima is described in the source content as a targeted therapy rather than traditional chemotherapy. It is often used alongside chemotherapy in some treatment plans, especially for certain cancers.
How it fits into a treatment plan depends on the condition being treated and the protocol chosen by the specialist team.
What to know about the package insert
The package insert is an important reference for healthcare professionals and patients. It provides details on preparation, administration, precautions, and monitoring. It also helps explain how the medicine should be handled and what safety information should be reviewed before treatment begins.
If you are unsure about any instruction in the leaflet, ask a pharmacist or the treating team to explain it in plain language.
Billing and coding information
The source content notes that billing and coding guidance may be used by healthcare providers for documentation and reimbursement. This information is mainly relevant to clinical and administrative teams.
Patients who have questions about coverage or costs should contact the clinic, pharmacy team, or insurer for clarification.
Safety reminders
Truxima can affect the immune system, so monitoring is important throughout treatment. Tell the healthcare team about any symptoms that develop during or after infusion, especially if they are severe or unusual.
Do not rely on this summary alone for treatment decisions. Always check the official leaflet supplied with the medicine and follow the instructions given by the prescribing clinician.
Frequently asked questions
▸ How do you prepare Truxima infusion?
The source content says preparation should be done carefully in a sterile setting, with the correct dose checked and the solution inspected before administration. Preparation should be handled by trained healthcare professionals.
▸ What are the box warnings for rituximab?
The source content mentions serious risks including infusion-related reactions and progressive multifocal leukoencephalopathy (PML). The official leaflet should be checked for the full warning information.
▸ What is rituximab?
Rituximab is a monoclonal antibody that targets CD20 on B-lymphocytes. It is used in some cancers and autoimmune diseases.
▸ What is the NDC for Truxima?
The National Drug Code is a product identifier used for tracking and billing. The exact code can vary by product presentation, so it should be confirmed from the packaging or official product information.
▸ How long does a Truxima infusion take?
The infusion time can vary. The source content notes that the first infusion may take several hours and later infusions may be shorter, depending on tolerance and the treatment protocol.
Safety reminder: If symptoms such as fever, chills, rash, breathing problems, or other unexpected reactions occur during or after treatment, seek urgent medical advice according to local guidance and the instructions from the healthcare team.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.